TRCT
IVDA icon

Tower Research Capital (TRC)’s Iveda Solutions IVDA Stock Holding History

Tower Research Capital (TRC)’s Portfolio IVDA Stock Details IVDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$777 Sell
2,372
-1
-0% – ﹤0.01% 4949
2026
Q1 		$610 Sell
2,373
-8
-0.3% -$4 ﹤0.01% 4828
2025
Q4 		$2K Sell
2,381
-2,081
-47% -$2.32K ﹤0.01% 4599
2025
Q3 		$5.98K Buy
4,462
+2,347
+111% +$4.23K ﹤0.01% 4187
2025
Q2 		$4.29K Sell
2,115
-101
-5% -$226 ﹤0.01% 4348
2025
Q1 		$5.01K Buy
2,216
+1,046
+89% +$3.37K ﹤0.01% 4174
2024
Q4 		$5.78K Sell
1,170
-674
-37% -$1.39K ﹤0.01% 4242
2024
Q3 		$3.08K Buy
1,844
+1,035
+128% +$3.21K ﹤0.01% 4898
2024
Q2 		$3.29K Buy
809
+5
+0.6% +$30 ﹤0.01% 4908
2024
Q1 		$5.78K Sell
804
-129
-14% -$763 ﹤0.01% 4491
2023
Q4 		$4.73K Sell
933
-274
-23% -$1.57K ﹤0.01% 4924
2023
Q3 		$8.27K Buy
1,207
+98
+9% +$753 ﹤0.01% 4368
2023
Q2 		$9.67K Sell
1,109
-197
-15% -$1.99K ﹤0.01% 4239
2023
Q1 		$14K Buy
1,306
+321
+33% +$3K ﹤0.01% 3889
2022
Q4 		$4K Sell
985
-4
-0.4% -$21 ﹤0.01% 5023
2022
Q3 		$5K Buy
989
+949
+2,373% +$8.37K ﹤0.01% 5147
2022
Q2 		$0 Buy
+40
New +$562 ﹤0.01% 6294

Other funds holding IVDA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tower Research Capital (TRC)'s IVDA Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Iveda Solutions (IVDA) stake by 0.04% in Q2 2026, cutting 1 share and leaving 2,372 shares worth $777. The position accounts for ﹤0.01% of the portfolio, ranked #4949.

Tower Research Capital (TRC) first reported a position in IVDA in Q2 2022 and has held it in 17 quarters since. The position peaked at $14K in Q1 2023. 12 funds tracked by Wall St. Rank hold IVDA as of Q2 2026.

  • Tower Research Capital (TRC) held 2,372 shares of Iveda Solutions worth $777 as of Q2 2026.
  • Tower Research Capital (TRC) sold 1 Iveda Solutions share in Q2 2026.
  • Iveda Solutions made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4949 holding.
  • Tower Research Capital (TRC) first reported a position in Iveda Solutions in Q2 2022 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s Iveda Solutions position peaked at $14K in Q1 2023.
  • 12 funds tracked by Wall St. Rank held Iveda Solutions as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.